A phase II trial of dexamethasone, high-dose cytarabine, and cisplatin (DHAP) in combination with rituximab as salvage treatment for patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.

被引：0
|
作者：
Mey, UJM
Strehl, JW
Orlopp, KS
Flieger, D
Birkmann, J
Ho, A
Kaiser, U
Neubauer, A
Glasmacher, AG
Schmidt-Wolf, IGH
机构：
[1] Univ Bonn, Dept Internal Med 1, D-5300 Bonn, Germany
[2] Klinikum Aschaffenburg, Dept Internal Med 2, Aschaffenburg, Germany
[3] Univ Erlangen Nurnberg, Dept Internal Med 5, Nurnberg, Germany
[4] Univ Heidelberg, Dept Internal Med 5, Heidelberg, Germany
[5] St Bernward Krankenhaus, Dept Internal Med 2, Hildesheim, Germany
[6] Univ Marburg, Dept Internal Med, Marburg, Germany
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4618
引用
收藏
页码：238B / 238B
页数：1
相关论文
共 50 条
  • [41] A gemcitabine, cisplatin and dexamethazone combination in patients with multiply relapsed Hodgkin's and non-Hodgkin's lymphoma.
    Emmanouilides, C
    Territo, M
    [J]. BLOOD, 1999, 94 (10) : 261B - 261B
  • [42] Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma
    Muringampurath-John, Disni
    Flowers, Christopher R.
    Toscano, Michael
    Chen Zhengjia
    Kaufman, Jonathan L.
    Arellano, Martha
    Bernal-Mizrachi, Leon
    Heffner, Leonard T.
    Lechowicz, Mary-Jo
    McLemore, Morgan
    Winton, Elliott
    Jaye, David L.
    Lonial, Sagar
    Khoury, Hanna Jean
    [J]. LEUKEMIA & LYMPHOMA, 2012, 53 (04) : 725 - 727
  • [43] Prevention of thrombocytopenia using thrombopoietin in high-dose cytarabine treatment of non-Hodgkin lymphoma.
    Huang, He
    Wang, Zhao
    Hong, Huangming
    Guo, Chengcheng
    Li, Xueying
    Zhang, Mengping
    Lin, Xiaoting
    Fang, Xiaojie
    Fu, Xiaohong
    Tian, Ying
    Li, Shanshan
    Liu, Tingzhi
    Liang, Chaoyong
    Lin, Jia Tian
    Shrestha, Prem Raj
    Xiao, Jian
    Zhang, Hongyu
    Cao, Yabing
    Zhai, Linzhu
    Lin, Tongyu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] FLUDAP: Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma
    Child, JA
    Johnson, SA
    Rule, S
    Smith, GM
    Morgan, GJ
    Johnson, PWM
    Prentice, AG
    Tollerfield, SM
    Wareham, E
    [J]. LEUKEMIA & LYMPHOMA, 2000, 37 (3-4) : 309 - 317
  • [45] Cologne high-dose sequential chemotherapy in relapsed and refractory aggressive non-Hodgkin lymphoma - results of a multicentre Phase II study
    Josting, A
    Sieniawski, M
    Staak, JO
    Glossmann, JP
    Diehl, V
    Engert, A
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S245 - S245
  • [46] A phase II trial of gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for patients with refractory or relapsed non-Hodgkin's lymphoma
    Park, B.
    Kim, W.
    Eom, H.
    Kim, J.
    Oh, S.
    Suh, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] Pixantrone Dimaleate in Combination With Fludarabine, Dexamethasone, and Rituximab in Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma
    Srokowski, Tomasz P.
    Liebmann, James E.
    Modiano, Manuel R.
    Cohen, Gary I.
    Pro, Barbara
    Romaguera, Jorge E.
    Kuepfer, Christine
    Singer, Jack W.
    Fayad, Luis E.
    [J]. CANCER, 2011, 117 (22) : 5067 - 5073
  • [48] Cologne high-dose sequential chemotherapy in relapsed and refractory aggressive Non-Hodgkin's lymphoma - Results of multicenter phase II study.
    Josting, A
    Sieniawski, M
    Staak, O
    Glossmann, JP
    Diehl, V
    Engert, A
    [J]. BLOOD, 2003, 102 (11) : 405A - 405A
  • [49] Phase II study of rituximab in combination with CHOP chemotherapy and GMCSF in patients with previously untreated aggressive non-Hodgkin's lymphoma.
    Venugopal, P
    Gregory, SA
    Wooldridge, J
    Yunus, F
    Adler, S
    Shammo, J
    Enschede, S
    O'Brien, T
    Franson, P
    Porter, C
    [J]. BLOOD, 2002, 100 (11) : 314B - 314B
  • [50] Oxaliplatin-Based Chemotherapy (Dexamethasone, High-Dose Cytarabine, and Oxaliplatin) ± Rituximab Is an Effective Salvage Regimen in Patients With Relapsed or Refractory Lymphoma
    Rigacci, Luigi
    Fabbri, Alberto
    Puccini, Benedetta
    Chitarrelli, Ida
    Chiappella, Annalisa
    Vitolo, Umberto
    Levis, Alessandro
    Lauria, Francesco
    Bosi, Alberto
    [J]. CANCER, 2010, 116 (19) : 4573 - 4579
12345